MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Memantine in the Treatment of Kleptomania

Phase 2
Completed
Conditions
Kleptomania
Interventions
First Posted Date
2009-04-14
Last Posted Date
2021-05-24
Lead Sponsor
University of Chicago
Target Recruit Count
12
Registration Number
NCT00880685
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Genetic Factors in Chronic Sinusitis

Recruiting
Conditions
Chronic Sinusitis
First Posted Date
2009-04-13
Last Posted Date
2025-02-04
Lead Sponsor
University of Chicago
Target Recruit Count
1200
Registration Number
NCT00880516
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Stress Testing and Cardiac Magnetic Resonance

Phase 4
Completed
Conditions
Coronary Disease
Interventions
First Posted Date
2009-03-30
Last Posted Date
2021-07-12
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00871260
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Initiating Transdermal Estradiol Therapy in Turner's Syndrome

Phase 1
Terminated
Conditions
Turner's Syndrome
Interventions
Drug: Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch
First Posted Date
2009-03-27
Last Posted Date
2014-03-11
Lead Sponsor
University of Chicago
Target Recruit Count
1
Registration Number
NCT00870220
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

🇺🇸

John Hopkins University, Baltimore, Maryland, United States

Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging

Not Applicable
Completed
Conditions
Coronary Disease
Interventions
First Posted Date
2009-03-09
Last Posted Date
2016-05-11
Lead Sponsor
University of Chicago
Target Recruit Count
120
Registration Number
NCT00857792
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Phase 3
Terminated
Conditions
Elevated Prostate Specific Antigen
Interventions
First Posted Date
2009-02-10
Last Posted Date
2014-08-01
Lead Sponsor
University of Chicago
Target Recruit Count
85
Registration Number
NCT00840294
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

Phase 2
Completed
Conditions
Pre-diabetes
Interventions
First Posted Date
2009-01-28
Last Posted Date
2017-02-10
Lead Sponsor
University of Chicago
Target Recruit Count
53
Registration Number
NCT00831129
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Vitamin D Levels in Children Undergoing Adenotonsillectomies and Controls

Completed
Conditions
Tonsillitis
First Posted Date
2009-01-27
Last Posted Date
2023-05-06
Lead Sponsor
University of Chicago
Target Recruit Count
60
Registration Number
NCT00829972
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries

Phase 2
Completed
Conditions
Hypertension
Diabetes
Interventions
First Posted Date
2009-01-27
Last Posted Date
2016-02-05
Lead Sponsor
University of Chicago
Target Recruit Count
70
Registration Number
NCT00829296
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Sleep Disturbances as a Risk Factor in Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Interventions
Other: Controls Short sleep
Other: CKD- sleep extension
First Posted Date
2009-01-06
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
40
Registration Number
NCT00817427
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath